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mM TRIS base pH 7.4, 100 mM NaCl, 1 mM DTT, 1% (v/v) glycerol) or BAG1 replacement buffer (5 μL, 20 mM TRIS base pH 7.4, 100 mM NaCl, 1 mM DTT, 1% (v/v) glycerol) was added to the corresponding wells of the assay plate. Fluorescence polarisation values for probe and HSP72 ± BAG1 were plotted using GraphPad prism 6.
K D determination with BAG1:
To each well, 5 μL containing probe molecule (20 nM in assay buffer) and BAG1 protein (1.4 μM in assay buffer) and increasing concentrations of HSP70 protein (5 μL, two-fold dilution series) were added. Fluorescence polarisation values for tracer control wells (10 nM probe in assay buffer only) were subtracted from each data point prior to data analysis. K D determination was performed using non-linear regression analysis (GraphPad Prism 6, one site-specific binding model).
Compound screen with and without BAG-1: Compounds (0.2 μL at 50 x screening concentration in DMSO) were dispensed using an ECHO 550 Liquid Handler (Labcyte Inc.). To the corresponding wells was added, 5 μL of probe molecule (20 nM in assay buffer), 2.5 μL of HSP72 (four times final concentration in assay buffer) and either 2.5 µL of BAG-1 (2.8 µM in 20 mM TRIS base pH 7.4, 100 mM NaCl, 1 mM DTT, 1% (v/v) glycerol) or 2.5 µL of BAG1 replacement buffer (20 mM TRIS base pH 7.4, 100 mM NaCl, 1 mM DTT, 1% (v/v) glycerol). The assay was performed in duplicate. Tracer controls (10 nM probe molecule only) and bound tracer controls (10 nM probe in the presence of appropriate protein concentration) were included on each assay plate.
IC 50 determination was performed using non-linear least squares curve fitting (GraphPad Prism 6, log(inhibitor) vs. responsevariable slope (four parameters)). in the presence (▼) and absence (▲) of 5 µM HSP72, ↔ represents the assay window at 10 nM probe concentration. All data points were tested in triplicate and are represented as the arithmetic mean ± SEM.
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Time ( with 700 nM BAG1 (blue) or without BAG1 (red). K D determination was performed using non-linear regression analysis (one sitespecific binding model), all data points were tested in triplicate and are represented as the arithmetic mean ± SEM. Competition experiments in the presence of BAG1 (red) were performed using 10 nM biaryl-ATTO-488, 700 nM BAG1 and 140 nM HSP70 to give a 50% bound fraction. Competition experiments in the absence of BAG1 (blue) were performed using 10 nM biaryl-ATTO-488 and 180 nM HSP70 to give a 50% bound fraction. IC 50 determination was performed using non-linear regression analysis (log(inhibitor) vs. response -Variable slope (four parameters)), all data points were tested in duplicate and are represented as the arithmetic mean ± SEM. 
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Chemistry Experimental
General experimental: Reagents and solvents were purchased from commercial suppliers (Acros, Alfa Aesar, Apollo, Cambridge peptides, Fisher scientific, Fluorochem, Lumiprobe, Manchester Organics, Sigma-Aldrich, Thermo Scientific and VWR) and used without further purification.
Analytical thin layer chromatography (TLC) was performed on pre-coated aluminium sheets (60 F245 nm, Merck) and visualised by short-wave UV light and potassium permanganate dips. Flash column chromatography was carried out using Merck silica gel 60 (40-65 µm).
Purification by semi-preparative HPLC was carried out using one of the following sets of conditions:
Method A) Chromatographic separation was carried out at room temperature using a Gilson GX-281 Liquid Handler system combined with a Gilson 322 HPLC pump (Gilson, Middleton, USA) over a 15 minute gradient elution (Grad15mins20mls.m) from 10:90 to 100:0 methanol:water (both modified with 0.1% formic acid) at a flow rate of 20 mL/min. UV-Vis spectra were acquired at 254 nm on a Gilson 156 UV-Vis detector (Gilson, Middleton, USA). Collection was triggered by UV signal, and collected using a
Gilson GX-281 Liquid Handler system (Gilson, Middleton, USA).
Method C) Chromatographic separation was carried out at room temperature using a 1200 Series Preparative HPLC (Agilent, Santa Clara, USA) with a Phenomenex Gemini column (5 µm, 250 x 10 mm, C18, Phenomenex, Torrance, USA) using a 15 minute gradient elution (Grad15min.m) from 10:90 to 100:0 methanol:water (both modified with 0.1% formic acid) at a flow rate of 5.0 mL/min. UV-Vis spectra were acquired at 254nm and 280nm on a 1200 Series Prep Scale diode array detector (Agilent, Santa Clara, USA). Collection was triggered by UV and collected on a 1200 Series Fraction Collector (Agilent, Santa Clara, USA).
1 H NMR spectra were recorded on a Bruker AMX500 (500 MHz) spectrometer using an internal deuterium lock. Chemical shifts were measured in parts per million (ppm) relative to tetramethylsilane (δ = 0) using the following residual solvent signals: CDCl 3 (δ H 7.26), CD 3 OD (δ H 3.32), and (CD 3 ) 2 SO (δ H 2.50). Multiplicities are recorded as singlet (s), doublet (d), triplet (t), quartet (q) and multiplet (m), doublet of doublets (dd), doublet of doublet of doublets (ddd), apparent (app), obscured (obs) and broad (br).
Coupling constants, J, are measured to the nearest 0.1 Hz. 13 C NMR spectra were recorded at 126 MHz on a Bruker Avance 500 MHz spectrometer using an internal deuterium lock. Chemical shifts were measured in parts per million (ppm) relative to tetramethylsilane (δ = 0) using the following residual solvent signals: CHCl 3 (δ C 77.16), CD 3 OD (δc 49.00) and (CD 3 ) 2 SO (δ C 39.52).
Chemical shifts are quoted to 0.1 ppm, unless greater accuracy is required. * Denotes peaks observed only in HSQC spectra.
High resolution mass spectrometry was performed on an Agilent 1200 series HPLC and diode array detector coupled to a 6210 time of flight mass spectrometer with dual multimode APCI/ESI source. Analytical separation was carried out at 30 °C on a Merck
Chromolith SpeedROD column (RP-18e, 50 x 4.6 mm) or a Merck Purospher STAR column (RP-18e, 30 x 4 mm) using a flow rate of 1.5 mL/min in a 4 minute gradient elution; solvents -aqueous (0.1% formic acid) and methanol. UV Detection was at 254 nm.
LC/MS analysis was performed on a Waters Alliance 2795 separations module and a Waters 2487 dual wavelength absorbance detector coupled to a Waters/Micromass LCT time of flight mass spectrometer with ESI source. Analytical separation was carried out at 30 o C on a Merck Purospher STAR column (RP-18e, 30 x 4 mm) using a flow rate of 1.5 mL/min in a 4 minute gradient elution with detection at 254 nm. 152. 1, 151.7, 151.2, 144.2, 132.2, 88.7, 85.9, 76.6, 72.0, 62.6, 26.3, 26.0, 25.8, 18.7, 18.2, 18.0, -4.2, -4.5, -4.6, -4.9, -5.15, -5.19 2R,3R,4R,5R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-5-(6-chloro-9H-purin-9-yl) ((2R,3R,4R,5R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol (0.70 g, 1.36 mmol) was dissolved in DMF (12.5 mL) and cooled to -78 °C before the addition of NaH (60% dispersion in oil) (0.07 g, 1.77 mmol) and 
6-Chloro-9-((3aR,4R,6R,6aR)-2,2-dimethyl-6-(((4-(trifluoromethyl) benzyl)oxy)methyl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-9H-purine (Compound 4)
layers were combined, washed with brine and dried over MgSO 4 . The solvent was partially evaporated under reduced pressure and the crude product recrystallized from EtOAc/water to give compound 6 as a white solid (0.93 g, quantitative yield)
9-((2R,3R,4R,5R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-5-(((4-(trifluoromethyl)benzyl)oxy)methyl)tetrahydrofuran-2-yl)-6-chloro-9H-purine (Compound 7)
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the reaction stirred for 15 minutes. 1-(Bromomethyl)-4-(trifluoromethyl)benzene (0.65 g, 2.72 mmol) in DMF (5 mL) was added and the reaction allowed to slowly warm to room temperature over 16 hours. The reaction mixture was diluted with H 2 O and extracted with EtOAc. The organic layers were combined, washed with brine and the solvent removed under reduced pressure.
The crude product was purified by column chromatography (8:2 cyclohexane/EtOAc) to give compound 7 as a colourless oil 
9-((2R,3R,4R,5R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-5-(((4-(trifluoromethyl)benzyl)oxy)methyl)tetrahydrofuran-2-yl)-6-chloro-N-(quinolin-6-ylmethyl)-9H-purin-8-amine (Compound 9)
1 M TBAF, THF
Compound 8 (90 mg, 0.12 mmol) was dissolved in THF (2.5 mL) and TBAF (1.0 M in THF, 3.1 eq) was added and the reaction stirred until complete by TLC analysis. The reaction mixture was diluted with MeOH, the solvent removed under reduced pressure to give the crude product. 63% of the isolated crude material was dissolved in EtOH (1.5 mL). Triethylamine (1.5 eq.) and quinolone-6-methyl amine (1.5 eq.) in EtOH (1.5 mL) were added and the reaction stirred at 40 °C for 16 hours under N 2 .
The solvent was removed under reduced pressure and the resulting solid taken up in CH 2 Cl 2 and H 2 O. The aqueous layer was extracted with CH 2 Cl 2 and the organic layers combined, washed with brine and dried over 152.7, 151.0, 150.7, 148.0, 143.1, 139.1, 138.2, 137.9, 135.8, 130.8 (q, J = 31.9 Hz), 130.42, 130.2, 129.8, 129.4, 128.8, 126.26 (q, J = 3.8 Hz), 125.9, 125.5*, 124.7*, 122.8, 117.8, 114.0*, 103.7, 88.7, 85.6, 73.7, 72.8, 72.2, 71.4, 46.6, 41.6, 41.11, 30.6, 30.3, 27.8, 27.6 Triethylamine (1 µl, 9 µmol) and ATTO488 NHS ester (6 mg, 9 µmol) were added to a solution of (2R,3R,4S,5R)-2-(6-( (6 147.0, 138.1, 135.7, 131.5, 129.3, 129.2, 128.9, 125.2, 125.0, 121.5, 118.7, 113.1, 87.0, 82.8, 71.9, 71.5, 70.6, 70.3, 46.0, 45.3, 30.7, 29.1, 26.24, 26.19, 25.2, 22.0 A B
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Figure S12. Ligand interaction analysis of Ver-155008 1 bound to HSP72-NBD. The N6-adenine position was solvent exposed so was selected as the point for fluorophore attachment. Figure S13 . The phosphate binding pocket of ADP/P i bound to HSP72-NBD. Our data is consistent with BAG1 causing a conformational change of the PBP to facilitate first P i dissociation, followed by ADP. Because BAG1 does not inhibit ligands binding to the adenine binding pocket, we hypothesised that the HSP72/BAG1 complex could represent a more druggable protein target than the HSP72 protein alone.
